SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'B5U'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AJ6_A_NOVA1_1 (GYRASE) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 9 | ASN A 52GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85THR A 169 | B5U A1256 (-3.2A)B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 (-3.6A) | 0.62A | 1aj6A-4b6cA:22.6 | 1aj6A-4b6cA:46.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 8 / 12 | ASP A 55GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85ARG A 141THR A 169 | NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.33A | 1kijA-4b6cA:22.5 | 1kijA-4b6cA:35.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 8 / 12 | ASN A 52GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.54A | 1kijB-4b6cA:22.9 | 1kijB-4b6cA:35.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 5 / 12 | ASN A 52ASP A 55GLU A 56ARG A 82ASP A 142 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.4A)None | 1.46A | 1s14A-4b6cA:25.8 | 1s14A-4b6cA:43.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 8 / 12 | ASN A 52ASP A 55GLU A 56ASP A 79ARG A 82PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.43A | 1s14A-4b6cA:25.8 | 1s14A-4b6cA:43.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 5 / 12 | ASN A 52ASP A 55GLU A 56ARG A 82ASP A 142 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.4A)None | 1.43A | 1s14B-4b6cA:24.9 | 1s14B-4b6cA:43.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 12 | ASN A 52ASP A 55GLU A 56ASP A 79ARG A 82PRO A 85ARG A 141 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A) | 0.51A | 1s14B-4b6cA:24.9 | 1s14B-4b6cA:43.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 8 / 12 | ASN A 52ASP A 55GLU A 56ASP A 79ARG A 82PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.35A | 3lpsA-4b6cA:23.9 | 3lpsA-4b6cA:25.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 11 | ASN A 52ASP A 55GLU A 56ASP A 79PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.70A | 4urnA-4b6cA:24.4 | 4urnA-4b6cA:46.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 11 | ASP A 55GLU A 56ASP A 79ARG A 82PRO A 85ARG A 141THR A 169 | NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.86A | 4urnA-4b6cA:24.4 | 4urnA-4b6cA:46.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 11 | ASN A 52ASP A 55GLU A 56ASP A 79PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.60A | 4urnB-4b6cA:25.7 | 4urnB-4b6cA:46.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 6 / 11 | GLU A 56ASP A 79ARG A 82PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.54A | 4urnB-4b6cA:25.7 | 4urnB-4b6cA:46.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 11 | ASN A 52ASP A 55GLU A 56ASP A 79PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.59A | 4urnC-4b6cA:24.8 | 4urnC-4b6cA:46.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 11 | ASP A 55GLU A 56ASP A 79ARG A 82PRO A 85ARG A 141THR A 169 | NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.75A | 4urnC-4b6cA:24.8 | 4urnC-4b6cA:46.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 6 / 12 | ASN A 52GLU A 56ASP A 79ILE A 84PRO A 85ARG A 141 | B5U A1256 (-3.2A)B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A) | 0.55A | 4uroA-4b6cA:24.8 | 4uroA-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 6 / 12 | GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85ARG A 141 | B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A) | 0.39A | 4uroA-4b6cA:24.8 | 4uroA-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 6 / 12 | ASN A 52GLU A 56ASP A 79ILE A 84PRO A 85ARG A 141 | B5U A1256 (-3.2A)B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A) | 0.54A | 4uroB-4b6cA:24.9 | 4uroB-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 6 / 12 | GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85ARG A 141 | B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A) | 0.36A | 4uroB-4b6cA:24.9 | 4uroB-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 6 / 12 | ASN A 52GLU A 56ASP A 79ILE A 84PRO A 85ARG A 141 | B5U A1256 (-3.2A)B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A) | 0.59A | 4uroC-4b6cA:24.8 | 4uroC-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 6 / 12 | GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85ARG A 141 | B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A) | 0.40A | 4uroC-4b6cA:24.8 | 4uroC-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 12 | ASN A 52GLU A 56ASP A 79ILE A 84PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.57A | 4uroD-4b6cA:24.6 | 4uroD-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 7 / 12 | GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.34A | 4uroD-4b6cA:24.6 | 4uroD-4b6cA:48.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NY7_A_NCAA303_0 (AMIDASE) |
4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) | 4 / 6 | ARG A 82PRO A 85THR A 169GLU A 56 | B5U A1256 (-3.4A)B5U A1256 (-4.2A)B5U A1256 (-3.6A)B5U A1256 (-3.6A) | 0.99A | 5ny7A-4b6cA:undetectable | 5ny7A-4b6cA:21.36 |